Re:Goldman Sachs questions whether curing patients is a sust...
by andrepd on Friday April 13, 2018 @12:58PM
(#16831771)
You can theorise all you want, but the world is rife with examples of what I said being true. As always, experiment must trump theory.
[ Parent
| on HN ]
Re:Goldman Sachs questions whether curing patients is a sust...
by andrewla on Friday April 13, 2018 @01:08PM
(#16831861)
Certainly there are lots of cases of expensive long-term treatments being developed.
Do you have examples of situations where cures have been suppressed in favor of expensive long-term treatments? Especially in a competitive environment, where there were multiple players offering competing long-term treatments that were both aware of cures?
Preferably this would be something supported by leaked or court documents, but independent investigations would also be interesting. I understand this is a high burden of proof, but everything I've seen seems to indicate that this is an urban myth. I certainly couldn't find any specific cases in a cursory search.
Re:Goldman Sachs questions whether curing patients is a sust...
by darawk on Friday April 13, 2018 @01:55PM
(#16832308)
Name literally one example of that being true. I'll wait.